MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,093,916 | +8.8% | 3,256,102 | 0.0% | 0.21% | +20.3% |
| Q2 2023 | $9,279,891 | -27.7% | 3,256,102 | 0.0% | 0.18% | -33.7% |
| Q1 2023 | $12,829,042 | -24.9% | 3,256,102 | -24.5% | 0.27% | -23.5% |
| Q4 2022 | $17,087,804 | -56.9% | 4,315,102 | 0.0% | 0.35% | -61.8% |
| Q3 2022 | $39,656,000 | +49.4% | 4,315,102 | 0.0% | 0.91% | +33.2% |
| Q2 2022 | $26,538,000 | -4.2% | 4,315,102 | 0.0% | 0.69% | +19.7% |
| Q1 2022 | $27,703,000 | -2.0% | 4,315,102 | 0.0% | 0.57% | +38.7% |
| Q4 2021 | $28,264,000 | +14.7% | 4,315,102 | 0.0% | 0.41% | +11.0% |
| Q3 2021 | $24,639,000 | +3.8% | 4,315,102 | 0.0% | 0.37% | +3.9% |
| Q2 2021 | $23,733,000 | -5.0% | 4,315,102 | 0.0% | 0.36% | -8.2% |
| Q1 2021 | $24,984,000 | -13.6% | 4,315,102 | 0.0% | 0.39% | -19.6% |
| Q4 2020 | $28,911,000 | -8.5% | 4,315,102 | 0.0% | 0.48% | -36.3% |
| Q3 2020 | $31,587,000 | +93.7% | 4,315,102 | 0.0% | 0.76% | +65.8% |
| Q2 2020 | $16,311,000 | +105.4% | 4,315,102 | 0.0% | 0.46% | +34.2% |
| Q1 2020 | $7,940,000 | -87.5% | 4,315,102 | +9.0% | 0.34% | -85.7% |
| Q4 2019 | $63,372,000 | -0.7% | 3,958,264 | +12.4% | 2.39% | -37.0% |
| Q3 2019 | $63,819,000 | -29.8% | 3,521,856 | 0.0% | 3.80% | -21.9% |
| Q2 2019 | $90,967,000 | – | 3,521,856 | – | 4.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |